Labaneb Respules (Arformoterol) | Used for COPD and Chronic Bronchitis Management
Labaneb Respules (Arformoterol) is a medication used to treat chronic respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) and asthma.
Product Overview
Labaneb Respules is an advanced, inhalation-based long-acting bronchodilator solution prescribed for the continuous maintenance management of respiratory disorders. Containing the active therapeutic compound Arformoterol (as arformoterol tartrate), this targeted inhalation solution is engineered to keep the pulmonary airways open over an extended duration. Labaneb is primarily utilized for the long-term management of airflow obstruction in patients suffering from Chronic Obstructive Pulmonary Disease (COPD), including emphysema and chronic bronchitis. Administered systematically through a nebulizer, it helps control chronic respiratory distress and enhances overall breathing capacity.
Product Composition
- Active Pharmaceutical Ingredient: Arformoterol Tartrate (formulated at 15mcg of pure arformoterol per 2ml unit-dose vial)
- Dosage Form: Clear, colorless, sterile aqueous solution designed exclusively for conversion into an inhalable mist via a nebulizer machine
- Core Excipients: Formulated in an isotonic saline solution containing citric acid and sodium citrate to maintain precise pH stability, with zero added preservatives
Product Specification
| Product Parameter | Details |
| Brand Name | Labaneb Respules |
| Active Ingredient | Arformoterol Tartrate |
| Therapeutic Class | Respiratory Agents / Long-Acting Beta2-Adrenergic Agonists (LABAs) |
| Available Strength | 15mcg / 2ml |
| Primary Indications | Long-term maintenance treatment of bronchoconstriction in Chronic Obstructive Pulmonary Disease (COPD) |
Mechanism of Action
- Beta2-Adrenergic Receptor Activation: Arformoterol functions as a highly selective, long-acting beta2-adrenergic receptor agonist. Upon inhalation, it directly targets the beta2 receptors abundant on the surface of bronchial smooth muscle cells.
- Intracellular Adenyl Cyclase Stimulation: Binding to these receptors stimulates intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP).
- Smooth Muscle Relaxation: Increased cellular cAMP levels trigger a cascade that leads to relaxation of the bronchial smooth muscles, successfully reversing bronchoconstriction and widening the pulmonary airways.
- Inflammatory Mediator Regulation: The compound also aids in stabilizing mast cells and inhibiting the localized release of hypersensitivity and inflammatory mediators, which assists in keeping air passages clear.
Key Benefits
- Provides continuous, long-acting bronchodilation that actively prevents airway constriction for up to 12 hours per single nebulized dose.
- Significantly diminishes the frequency and severity of debilitating COPD symptoms, including chronic wheezing, shortness of breath, daytime coughing, and chest tightness.
- Improves overall baseline lung function, allowing patients with chronic respiratory conditions to perform daily physical activities with greater comfort.
- Delivers the active therapeutic compound directly to the lung tissue via localized inhalation, optimizing bronchodilatory effects while maintaining low systemic drug concentrations.
Precautions
Important Precautions for Labaneb Respules (Arformoterol)
Labaneb Respules is a long-acting bronchodilator used for COPD maintenance therapy. It should be used carefully to ensure safe and effective respiratory control.
| Precaution Area | Details |
|---|---|
| Asthma Use | Not for sudden asthma attacks (rescue use). |
| Heart Conditions | May increase heart rate or palpitations. |
| Thyroid Disorders | Use with caution in hyperthyroidism. |
| Diabetes | May affect blood sugar levels. |
| Seizure Disorders | Use carefully in epilepsy patients. |
| Pregnancy | Use only if clearly prescribed. |
| Overuse | Do not exceed prescribed dosing schedule. |
Important Safety Advice
- Use regularly as prescribed, not for emergency relief
- Do not stop abruptly without medical advice
- Use only via nebulizer as directed
- Monitor breathing improvement consistently
- Report chest pain or severe palpitations
When to Avoid Labaneb Respules
- Acute bronchospasm (emergency breathing attack)
- Known hypersensitivity to Arformoterol
- Severe uncontrolled heart rhythm disorders
Monitoring Requirements
- Heart rate and blood pressure monitoring
- Lung function assessment
- Blood sugar monitoring in diabetic patients
- Symptom tracking for COPD control
General Note
- Intended for long-term COPD management
- Not a rescue inhalation therapy
- Regular follow-up improves treatment safety and effectiveness
Usage
This long-acting inhalation solution must be administered on a consistent, twice-daily schedule to maintain continuous bronchodilation. Because this medication is formulated for long-term maintenance, it should be taken at the same times every day regardless of whether the patient is experiencing active respiratory symptoms. Regular respiratory assessments are recommended to evaluate the long-term effectiveness of the therapy.
| Parameter | Clinical Guidelines |
| Administration Route | For oral inhalation via a standard jet nebulizer only. The sterile solution must be poured directly into the nebulizer cup. It should never be swallowed, injected, or mixed with other inhalation drugs. |
| Rescue Therapy Rule | Do not use this medication to treat sudden, acute episodes of breathlessness. Always keep a short-acting rescue bronchodilator available for immediate relief during an acute bronchospasm. |
| Cardiovascular Check | Patients with pre-existing heart conditions, high blood pressure, or irregular heartbeats should monitor their pulse rate regularly, as beta2-agonists can cause temporary cardiac stimulation. |
Uses
Long-Term Maintenance of COPD Airflow Obstruction: Indicated for the twice-daily, continuous treatment of reversible bronchoconstriction in patients with Chronic Obstructive Pulmonary Disease, including chronic bronchitis and emphysema.
Prevention of Chronic Wheezing and Dyspnea: Utilized to control and minimize the daily occurrence of severe wheezing, shortness of breath, and chest tightness by keeping the bronchial smooth muscles relaxed.
Baseline Pulmonary Function Improvement: Prescribed to improve overall baseline lung capacity and expiratory airflow over time, helping patients maintain a higher level of daily physical activity.
Extended Bronchoconstriction Prophylaxis: Employed specifically to provide a stable, 12-hour window of respiratory protection per dose, preventing the sudden narrowing of airways during rest or routine daily exertion.
Side Effects
Possible Side Effects of Labaneb Respules (Arformoterol)
Labaneb Respules is generally well tolerated when used for COPD maintenance therapy. However, some patients may experience side effects due to its bronchodilator action.
| Side Effect Type | Details |
|---|---|
| Common Effects | Tremors, headache, dizziness. |
| Heart Effects | Palpitations, fast heart rate. |
| Respiratory Effects | Throat irritation, cough. |
| Muscle Effects | Muscle cramps or weakness. |
| Metabolic Effects | Low potassium levels (rare). |
| General Effects | Nervousness or restlessness. |
Common Side Effects
- Tremors
- Headache
- Dry mouth or throat irritation
- Mild dizziness
Less Common But Important Effects
- Fast or irregular heartbeat
- Muscle cramps
- Increased blood pressure
- Low potassium levels
When to Be Careful
- Chest pain or severe palpitations
- Worsening breathing difficulty
- Severe dizziness or fainting
- Signs of allergic reaction
General Note
- Side effects are usually dose-related
- Not intended for sudden breathing emergencies
- Report persistent or severe symptoms promptly
FAQs
Q: What is Labaneb Respules used for?
A: This inhalation solution is used for the long-term, twice-daily maintenance treatment of airflow obstruction in patients with Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema.
Q: Can Labaneb Respules be used to treat an acute asthma attack?
A: No, this medication is a long-acting beta-agonist (LABA) and does not replace a fast-acting rescue inhaler. It will not treat sudden, acute breathing distress or bronchospasms. A short-acting rescue bronchodilator must always be available for immediate symptom relief.
Q: How should this inhalation solution be administered?
A: This medication must be administered exclusively via a standard jet nebulizer connected to an air compressor. The solution is inhaled through a mouthpiece or face mask. It must never be swallowed, injected, or mixed with other medications in the nebulizer cup.
Q: What are the common side effects associated with Arformoterol?
A: The most common side effects include a mild tremor (particularly in the hands), nervousness, headache, dry mouth, or diarrhea. Because it stimulates beta receptors, some patients may also experience an increased heart rate, palpitations, or a transient rise in blood pressure.
Q: Are there any serious cardiovascular warnings with this drug?
A: Yes, like other beta2-agonists, arformoterol can produce significant cardiovascular effects in some patients, such as increased pulse rate, elevated blood pressure, or cardiac arrhythmias. It must be used with caution in individuals with underlying cardiovascular disorders, coronary insufficiency, or cardiac arrhythmias.
Q: How should the individual respules be stored?
A: The vials must be stored in their protective foil pouches to shield them from light and physical damage. It is recommended to store them in a refrigerator; however, if unrefrigerated, they must be stored at room temperature and used within the timeframe specified by the product manufacturer.
Interactions
Drug Interactions of Labaneb Respules (Arformoterol)
Labaneb Respules (Arformoterol) may interact with medicines that affect the heart, breathing system, or potassium levels. These interactions can increase side effects like palpitations or reduce safety.
| Medicine or Product Type | Interaction Details |
|---|---|
| Other Bronchodilators | May increase side effects like tremors or fast heartbeat. |
| Beta-blockers | Can reduce effectiveness of Arformoterol. |
| Diuretics (Water Pills) | May increase risk of low potassium levels. |
| Antidepressants (MAOIs/TCAs) | Can increase cardiovascular side effects. |
| Steroids | May increase risk of low potassium when combined. |
| Digoxin | Low potassium may increase toxicity risk. |
Important Interaction Advice
- Avoid using multiple inhaled bronchodilators without advice
- Inform doctor about heart and blood pressure medicines
- Monitor for palpitations or muscle weakness
- Use caution if taking diuretics or steroids
General Guidance
- Regular monitoring of heart rate and electrolytes may be needed
- Do not mix medications in nebulizer unless directed
- Report chest pain, tremors, or irregular heartbeat
- Always follow COPD treatment plan strictly
Additional Note
- Labaneb Respules should be used carefully in patients with heart disease or electrolyte imbalance due to interaction risks
| Manufacturer | : | Lupin Pharma, India |
| Trade Name | : | Brovana |
| Generic Search | : | Arformoterol |
| Strength | : | 15mcg |
Latest Products
